认知
嗅觉系统
疾病
神经科学
嗅觉记忆
嗅觉
痴呆
感觉系统
功能磁共振成像
阿尔茨海默病
认知功能衰退
医学
心理学
中枢神经系统
嗅球
内科学
作者
Yajing Zhu,Qian Chen,Futao Chen,Jiaming Lu,Cong Long,Danni Ge,Xinru Xu,Lei Yan,Xi Wu,Shunshun Du,Yijun Bai,Dongming Liu,Yingxin Chen,Shengxian Fan,Huiquan Yang,Zhengyang Zhu,Bing Zhang,Qing X. Yang,Bing Zhang
标识
DOI:10.1177/13872877251373017
摘要
Background Individuals with subjective cognitive decline (SCD) are at high risk of preclinical Alzheimer's disease (AD). While olfactory dysfunction is evident in AD and mild cognitive impairment (MCI), its presence and neural mechanism in SCD remain unclear. Objective This study examined functional connectivity (FC) alterations across olfactory networks and their mediating role between olfactory and cognitive functions in SCD and MCI. Methods Eighty SCD, 51 MCI, and 80 normal controls underwent cognitive and olfactory tests and resting-state functional magnetic resonance imaging scanning. Two olfactory networks (primary and advanced), each with six selected spherical regions, were defined. We compared FCs within and between networks, examined correlations with olfactory and cognitive functions, performed mediation analysis, and evaluated classification via receiver operating characteristic curves. Results SCD participants presented increased FCs in key regions with normal olfactory scores, while MCI patients exhibited reduced FCs and olfactory scores. Altered FCs correlated with olfactory performance and mediated the relationship between olfactory and cognitive functions. FC features effectively distinguished SCD from normal controls. Conclusions Increased FCs in SCD indicated a significant compensatory neural mechanism for the disrupted FCs in MCI, leading to an apparent normal olfactory function in SCD participants. Moreover, the findings suggest that olfactory deficits may be associated with cognitive decline rather than solely impaired olfactory sensory processing. As such olfactory deficits could be a proxy for cognitive decline in AD and the altered FCs could aid in the early detection of individuals at high risk for preclinical AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI